Ashish Mandelia

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 36% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Vice President, Controller Mersana Therapeutics Inc July 1, 2019 - Dec. 31, 2019
Ashish Mandelia's trades of Mersana Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-17 2025-01-16
PlS Planned sale
13,095 +14.4%
246.63
US$553,374 		13,095 +14.4% 246.63 US$553,374
2025-01-16 2025-01-15
PlS Planned sale
25,753 -49.3%
469.97
US$4,579,521 		25,753 -49.3% 469.97 US$4,579,521
2025-01-15 2025-01-14
PlS Planned sale
13,269 +46.4%
100.71
US$1,594,013 		13,269 +46.4% 100.71 US$1,594,013
2024-10-07 2024-10-03
PlS Planned sale
3,361 -6.6%
1.96
US$6,588 		3,361 -6.6% 1.96 US$6,588
2024-10-07 2024-10-02
PlS Planned sale
4,855 -8.7%
2.00
US$9,710 		4,855 -8.7% 2.00 US$9,710
2024-01-17 2024-01-16
PlS Planned sale
5,025 -17.7%
2.71
US$13,618 		5,025 -17.7% 2.71 US$13,618
2023-01-18 2023-01-17
S Sale
3,575 -20.8%
5.74
US$20,520 		3,575 -20.8% 5.74 US$20,520
2022-01-19 2022-01-18
S Sale
1,982 -37.0%
5.92
US$11,733 		1,982 -37.0% 5.92 US$11,733
2021-01-20 2021-01-19
PlS Planned sale
545 -100.0%
21.28
US$11,598 		545 -100.0% 21.28 US$11,598
2021-01-06 2021-01-04
PlS Planned sale
247 -100.0%
26.76
US$6,610 		247 -100.0% 26.76 US$6,610
2020-07-06 2020-07-02
PlS Planned sale
3,383 -100.0%
22.49
US$76,084 		3,383 -100.0% 22.49 US$76,084
2020-07-06 2020-06-30
B Purchase
3,383 +inf%
4.87
US$16,475 		3,383 +inf% 4.87 US$16,475